Blood Test

A cell-free DNA multicancer early detection test demonstrated an ability to predict cancer and the tissue of origin in individuals with clinical suspicion of cancer, according to results of the Circulating Cell-free Genome Atlas study presented at the virtual American Association for Cancer Research Annual Meeting.

An investigational blood-based assay demonstrated efficacy in detecting multiple types of cancer, including gastrointestinal cancers, at various stages, according to study results presented at Gastrointestinal Cancers Symposium.

Differences in the expression level of circulating microRNAs, assessed via a blood test, are positively associated with total sleep duration among healthy, normal-weight children and adolescents, according to findings published in Experimental Physiology.

Abbott announced that a high-sensitivity troponin I blood test used to detect MI has received FDA clearance.

Using a novel blood-based biomarker panel, researchers detected warzone-related PTSD in male combat veterans with 81% accuracy and 77% specificity.